XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more
XOMA is expected to report earnings to rise 5.01% to 17 cents per share on July 30
Q2'26
Est.
$0.18
Q1'26
Beat
by $0.12
Q4'25
Beat
by $0.37
Q3'25
Beat
by $0.79
Q2'25
Beat
by $0.64
The last earnings report on April 30 showed earnings per share of 16 cents, beating the estimate of 4 cents. With 3.17M shares outstanding, the current market capitalization sits at 710.86M.